Publicity. Neither Party will issue a press release or any other public announcement regarding this Agreement or the settlement of the Litigation unless the other Party provides prior consent in writing. Notwithstanding the foregoing and Section 6.2 above, upon inquiry either Party may state that Enzo and [[Party:Organization]] have entered into a settlement agreement.

Publicity. No publicity release or announcement concerning this Agreement or the transactions contemplated hereby shall be issued by either party hereto at any time from the signing hereof without advance approval in writing of the form and substance by the other party.

Publicity. The Consultant shall not make any public disclosures regarding the Client, its subsidiaries or affiliates or the project for which he is performing the Work without the prior approval of the Client, or unless compelled by law or by rules of the U.S. Securities and Exchange Commission, (the "SEC").

No Publicity. Neither Party shall use the name, trade name, service marks, trademarks, trade, dress or logos of the other Party in publicity releases, advertising or any other publication without the prior written consent of that Party.

Disclosure; Publicity. The Company shall consult with the Purchaser in issuing any press releases or other public statement or disclosure (including any filing, communication or disclosure required to be or voluntarily filed with or made to the SEC, the NYSE or any other governmental or regulatory agency) with respect to the transactions contemplated hereby or that otherwise names or references the Purchaser or any of its Affiliates, and the Company shall not issue any such press release or other public statement without the prior consent of the Purchaser (which consent shall not unreasonably be withheld or delayed), except if such disclosure is required by law, in which case the Company shall promptly provide the Purchaser with prior notice of such public statement or communication and, to the extent practicable, reasonably cooperate with the Purchaser regarding such disclosure. For the avoidance of doubt, the foregoing shall apply to any and all registration statements filed by the Company pursuant to the Registration Rights Agreement or otherwise, regardless of whether any securities held by the Purchaser or any of its Affiliates are contained thereon. The Purchaser may make customary announcements relating to the transaction, including use of the Company’s name and logo in connection therewith.

[[Organization B:Organization]] shall ensure that:

Publicity/Publication. Neither Party will publicly disclose the existence or substance of this Agreement, except as required by applicable laws or in filings with Regulatory Authorities. Neither Party will use the name of the other Party or of any of its employees without such Party’s prior written consent.

Each Party (the receiving Party) shall keep confidential, shall not disclose to third persons and shall not use for any purpose any Confidential Information of the other Party (the disclosing Party) without the prior written consent of the disclosing Party, except to its employees, officers, representatives or advisers to the extent necessary to exercise its rights or perform its obligations under this Agreement. The receiving Party shall ensure that its employees, officers, representatives or advisers to whom it discloses the Confidential Information of the other Party comply with Section 4 of this Agreement. Paragraphs 47.02, 47.03 and 47.05 of the License and Supply Agreement shall apply to this Agreement, mutatis mutandis (except that, for clarity, the exceptions set forth in Paragraphs 47.03(i) and 47.03(ii) shall not apply to Recordati as the receiving Party), and are hereby incorporated into this Agreement by reference. For purposes of Section 4 of this Agreement: # “Confidential Information” means all Know-How and other proprietary scientific, marketing, financial or commercial information or data that is not publicly available, and which one Party or any of its Affiliates has supplied or otherwise made available to the other Party or its Affiliates under this Agreement, whether made available orally, in writing, or in electronic or visual form; and # the terms and conditions of this Agreement shall be deemed the Confidential Information of both Parties (and both Parties shall be deemed the receiving Party and the disclosing Party with respect thereto). The obligations with respect to any Confidential Information under Section 4 of this Agreement shall remain valid and in force for so long as such information remain confidential and not in the public domain.

No Publicity. A Party may not use the name of the other Party in any publicity or advertising and may not issue a press release or otherwise publicize or disclose any information related to the existence of this Agreement or the terms or conditions herein, except # on the advice of its counsel as required by law (e.g., any Securities and Exchange Commission filings and disclosures) and provided the Party who will be disclosing such information has consulted with the other Party to the extent feasible prior to such disclosure with respect to the substance of the disclosure; and # that any press release with respect to the existence of this Agreement or the terms or conditions herein shall be subject to each party’s prior review and approval; and, such approval shall not be unreasonably withheld. Licensee shall provide Merck with reasonable advance written notice of any press release or other public disclosure of the results of any of its work on Licensed Product under this Agreement.

Securities Laws Disclosure; Publicity. [[Organization B:Organization]] shall within three (3) Trading Days immediately following the Closing # issue a press release disclosing the material terms of the transactions contemplated hereby, and # file a Current Report on Form 8-K, including the Exchange Documents as exhibits thereto, with the Securities and Exchange Commission (the “Commission”) within the time required by the Exchange Act. [[Organization B:Organization]] and [[Organization A:Organization]] shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither [[Organization B:Organization]] nor [[Organization A:Organization]] shall issue any such press release nor otherwise make any such public statement without the prior consent of [[Organization B:Organization]], with respect to any press release of [[Organization A:Organization]], or without the prior consent of [[Organization A:Organization]], with respect to any press release of [[Organization B:Organization]], which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, [[Organization B:Organization]] shall not publicly disclose the name of [[Organization A:Organization]], or include the name of [[Organization A:Organization]] in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of [[Organization A:Organization]], except # as required by federal securities law in connection with the filing of final Exchange Documents (including signature pages thereto) with the Commission and # to the extent such disclosure is required by law or Trading Market regulations, in which case [[Organization B:Organization]] shall provide [[Organization A:Organization]] with prior notice of such disclosure permitted under this Section 6(c).